0001161697-23-000185.txt : 20230324
0001161697-23-000185.hdr.sgml : 20230324
20230324170014
ACCESSION NUMBER: 0001161697-23-000185
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230322
FILED AS OF DATE: 20230324
DATE AS OF CHANGE: 20230324
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRANDE ALICIA
CENTRAL INDEX KEY: 0001402652
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 23760621
MAIL ADDRESS:
STREET 1: 220 MIRACLE MILE
STREET 2: SUITE 234
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 03-22-2023
X0407
4
2023-03-22
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001402652
GRANDE ALICIA
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
VP, Treasurer and CFO
0
Common stock, par value $0.001 per share
2023-03-22
4
M
0
3260
0.79
A
53817
D
Common stock, par value $0.001 per share
2023-03-22
4
S
0
3260
16.41
D
50557
D
Common stock, par value $0.001 per share
2023-03-22
4
M
0
38524
0.79
A
89081
D
Common stock, par value $0.001 per share
2023-03-22
4
S
0
38524
16.51
D
50557
D
Options to purchase common stock
0.79
2023-03-22
4
M
0
3260
0
D
2023-06-15
Common Stock
3260
1442574
D
Options to purchase common stock
0.79
2023-03-22
4
M
0
38524
0
D
2023-06-15
Common Stock
38524
1404050
D
Shares were sold in various lots from $16.40 to $16.425 per share. The listed sale price represents a weighted average price for the shares sold.
Shares were sold in various lots from $16.50 to $16.555 per share. The listed sale price represents a weighted average price for the shares sold.
Shares were sold to cover exercise price of options, tax withholding requirements and for personal reasons. Shares were not sold as a result of any disagreement with the Company and Ms. Grande remains an officer of the Company.
Options vested in two annual tranches beginning on June 15, 2017.
/s/ Alicia Grande
2023-03-24